[
  {
    "ts": null,
    "headline": "Dividend Roundup: Why CVS Health Is Still Better Than Walgreens",
    "summary": "Walgreensâs recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. Read more on what investors need to know about these retailers.",
    "url": "https://finnhub.io/api/news?id=41c0edb2c2a55b07643e24343a71f54aed2844d2a0eba239ef00e1938ce68c04",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739193771,
      "headline": "Dividend Roundup: Why CVS Health Is Still Better Than Walgreens",
      "id": 132634975,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157593000/image_157593000.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Walgreensâs recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. Read more on what investors need to know about these retailers.",
      "url": "https://finnhub.io/api/news?id=41c0edb2c2a55b07643e24343a71f54aed2844d2a0eba239ef00e1938ce68c04"
    }
  },
  {
    "ts": null,
    "headline": "Tweedy, Browne Fund Q3 2024 Commentary",
    "summary": "Tweedy, Browne Fund Q3 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=418c89f80d97ba35dbb8000096bad5b383ea4a29ec43be4e73f1b04fb69ac892",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739188200,
      "headline": "Tweedy, Browne Fund Q3 2024 Commentary",
      "id": 132634641,
      "image": "",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=418c89f80d97ba35dbb8000096bad5b383ea4a29ec43be4e73f1b04fb69ac892"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Global Value Improvers Strategy Q4 2024 Commentary",
    "summary": "The ClearBridge Global Value Improvers Strategy outperformed its MSCI World Value benchmark during Q4 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=04a6cc6384e5428124ad5d3acbfa978d0323850881a377f00981946ec584cad3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739150100,
      "headline": "ClearBridge Global Value Improvers Strategy Q4 2024 Commentary",
      "id": 132630188,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1335295813/image_1335295813.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The ClearBridge Global Value Improvers Strategy outperformed its MSCI World Value benchmark during Q4 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=04a6cc6384e5428124ad5d3acbfa978d0323850881a377f00981946ec584cad3"
    }
  }
]